NCOA3 and Miyoshi myopathy: Another contribution of our present study in regard to elucidation of SRC-3 in MM chemoresistance is that elevated SRC-3 in MM may be induced specifically by proteasome inhibitors, because RR patients in our study were treated with several rounds of BTZ-based regimens.